Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo

References

• Perez-Herrero E, Fernandez-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharmaceut Biopharmaceut. 2015;93:52–79.
   PubMed Web of Science ®Google Scholar
• Aberoumandi SM, Mohammadhosseini M, Abasi E, et al. An update on applications of nanostructured drug delivery systems in cancer therapy: a review. Artif Cells Nanomed Biotechnol. 2016. [Epub ahead of print]. DOI:10.1080/21691401.2016.1228658.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Arpicco S, et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release. 2003;91:417–429.
   PubMed Web of Science ®Google Scholar
• Gao W, Xiang B, Meng TT, et al. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials. 2013;34:4137–4149.
   PubMed Web of Science ®Google Scholar
• Sawant RR, Torchilin VP. Challenges in development of targeted liposomal therapeutics. AAPS J. 2012;14:303–315.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 2007;9:128–147.
   PubMed Web of Science ®Google Scholar
• Lee E, Kim H, Lee IH, et al. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Control Release. 2009;140:79–85.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon HY, Koo H, et al. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and pluronic(R) for tumor-targeted delivery of docetaxel. Biomaterials. 2011;32:7181–7190.
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Coll Surf B Biointerf. 2010;75:1–18.
   PubMed Web of Science ®Google Scholar
• Lee SW, Yun MH, Jeong SW, et al. Development of docetaxel-loaded intravenous formulation, nanoxel-PM using polymer-based delivery system. J Control Release. 2011;155:262–271.
   PubMed Web of Science ®Google Scholar
• Ostacolo L, Marra M, Ungaro F, et al. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: do nanocarrier properties have a role?. J Control Release. 2010;148:255–263.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136–151.
   PubMed Web of Science ®Google Scholar
• Asadi N, Davaran S, Panahi Y, et al. Application of nanostructured drug delivery systems in immunotherapy of cancer: a review. Artif Cells Nanomed Biotechnol. 2017;45:18–23.
   PubMed Web of Science ®Google Scholar
• Maeda T, Fujimoto K. A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating. Coll Surf B Biointerf. 2006;49:15–21.
   PubMed Web of Science ®Google Scholar
• Kuai R, Yuan W, Qin Y, et al. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Mol Pharmaceutics. 2010;7:1816–1826.
   PubMed Web of Science ®Google Scholar
• Koren E, Apte A, Jani A, et al. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. J Control Release. 2012;160:264–273.
   PubMed Web of Science ®Google Scholar
• Sonawane SJ, Kalhapure RS, Govender T. Hydrazone linkages in pH responsive drug delivery systems. Eur J Pharmaceut Sci. 2016;99:45–65.
   PubMed Web of Science ®Google Scholar
• Mok H, Bae KH, Ahn CH, et al. PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. Langmuir. 2009;25:1645–1650.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Akita H, Kogure K, et al. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. 2007;14:68–77.
   PubMed Web of Science ®Google Scholar
• Xu H, Deng Y, Chen D, et al. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J Control Release. 2008;130:238–245.
   PubMed Web of Science ®Google Scholar
• McNeeley KM, Karathanasis E, Annapragada AV, et al. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 2009;30:3986–3995.
   PubMed Web of Science ®Google Scholar
• Raucher D, Ryu JS. Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol Med. 2015;21:560–570.
   PubMed Web of Science ®Google Scholar
• Mussa Farkhani S, Asoudeh Fard A, Zakeri-Milani P, et al. Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides. Artif Cells Nanomed, Biotechnol. 2016. [Epub ahead of print]. DOI:10.1080/21691401.2016.1200059.
   PubMed Web of Science ®Google Scholar
• Vives E, Schmidt J, Pelegrin A. Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta. 2008;1786:126–138.
   PubMed Web of Science ®Google Scholar
• Yuan H, Luo K, Lai Y, et al. Novel poly(l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions. Mol Pharmaceutics. 2010;7:953–962.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang ZY, Zhang J, et al. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain. Biomacromolecules. 2014;15:1010–11018.
   PubMed Web of Science ®Google Scholar
• Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2012;64:342–352.
   Web of Science ®Google Scholar
• Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol. 2009;13:256–262.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Y, Ma Q, et al. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Artif Cells Nanomed Biotechnol. 2016. [Epub ahead of print]. DOI:10.1080/21691401.2016.1260578.
   Web of Science ®Google Scholar
• Park JH, Cho HJ, Yoon HY, et al. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J Control Release. 2014;174:98–108.
   PubMed Web of Science ®Google Scholar
• Han C, Li Y, Sun M, et al. Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo. Artif Cells Nanomed Biotechnol. 2014;42:161–166.
   PubMed Web of Science ®Google Scholar
• Grünwald V, Hidalgo M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst. 2003;95:851–867.
   PubMed Web of Science ®Google Scholar
• Han CY, Yue LL, Tai LY, et al. A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro. Int J Nanomed. 2013;8:1541–1549.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Gidwani B, Vyas A. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:27–40.
   PubMed Web of Science ®Google Scholar
• Fernandes RS, Silva JO, Monteiro LO, et al. Doxorubicin-loaded nanocarriers: a comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy. Biomed Pharmacother. 2016;84:252–257.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu J, Zhang Q, et al. Enhanced cellular uptake and anti-proliferating effect of chitosan hydrochlorides modified genistein loaded NLC on human lens epithelial cells. Int J Pharm. 2014;471:118–126.
   PubMed Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, et al. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6:715–728.
   PubMed Web of Science ®Google Scholar